We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1176
Freshworks
FRSH
$3.72B
| $870K | ﹤0.01% |
58,377
+17,318
| +42% | +$250K |
2023 Q2
8 quarters
|
|
1177
Olin
OLN
$1.77B
| $867K | ﹤0.01% |
43,161
+32,205
| +294% | +$669K |
2013 Q2
48 quarters
|
|
1178
Crane Co
CR
$11.8B
| $866K | ﹤0.01% |
4,562
-44
| -1% | -$7.3K |
2023 Q2
8 quarters
|
|
1179
Paylocity
PCTY
$8.81B
| $864K | ﹤0.01% |
4,770
-45
| -0.9% | -$8.45K |
2017 Q3
31 quarters
|
|
1180
Cigna
CI
$78.9B
| $864K | ﹤0.01% |
2,614
-882
| -25% | -$284K |
2013 Q2
48 quarters
|
|
1181
Optimum Communications Inc
OPTU
$365M
| $863K | ﹤0.01% |
403,370
-3,300
| -0.8% | -$7.74K |
2017 Q4
30 quarters
|
|
1182
Omega Healthcare
OHI
$13.8B
| $859K | ﹤0.01% |
23,444
+244
| +1% | +$9.06K |
2013 Q2
48 quarters
|
|
1183
Fabrinet
FN
$13.5B
| $859K | ﹤0.01% |
2,915
-8
| -0.3% | -$1.78K |
2022 Q2
12 quarters
|
|
1184
Zions Bancorporation
ZION
$9.22B
| $858K | ﹤0.01% |
16,510
+2,508
| +18% | +$118K |
2013 Q2
48 quarters
|
|
1185
HUB Group
HUBG
$1.64B
| $858K | ﹤0.01% |
25,651
-936
| -4% | -$31.4K |
2022 Q3
11 quarters
|
|
1186
Avantor
AVTR
$10.9B
| $856K | ﹤0.01% |
63,613
-259,460
| -80% | -$3.55M |
2019 Q2
24 quarters
|
|
1187
Ecovyst
ECVT
$1.1B
| $855K | ﹤0.01% |
103,900
-18,470
| -15% | -$130K |
2023 Q1
9 quarters
|
|
1188
RLJ Lodging Trust
RLJ
$1.78B
| $851K | ﹤0.01% |
116,843
+10,868
| +10% | +$78.3K |
2016 Q3
35 quarters
|
|
1189
Silvaco Group
SVCO
$217M
| $850K | ﹤0.01% |
180,000
+54,000
| +43% | +$256K |
2024 Q2
4 quarters
|
|
1190
New York Times
NYT
$11.2B
| $848K | ﹤0.01% |
15,148
-303
| -2% | -$16.1K |
2013 Q2
48 quarters
|
|
1191
Frontdoor
FTDR
$5.36B
| $847K | ﹤0.01% |
14,376
-88,318
| -86% | -$4.43M |
2022 Q2
12 quarters
|
|
1192
Bloom Energy
BE
$68.5B
| $847K | ﹤0.01% |
+35,409
| New | +$686K |
2025 Q2
0 quarters
|
|
1193
Healthcare Realty
HR
$5.91B
| $847K | ﹤0.01% |
53,385
+11,993
| +29% | +$182K |
2020 Q3
19 quarters
|
|
1194
American Financial Group
AFG
$12.1B
| $846K | ﹤0.01% |
6,705
-134
| -2% | -$16.8K |
2013 Q2
48 quarters
|
|
1195
MasterBrand
MBC
$1.39B
| $845K | ﹤0.01% |
+77,275
| New | +$855K |
2025 Q2
0 quarters
|
|
1196
DELISTED
MRC Global
MRC
| $844K | ﹤0.01% |
61,549
-41,287
| -40% | -$498K |
2013 Q2
48 quarters
|
|
1197
Primerica
PRI
$8.62B
| $839K | ﹤0.01% |
3,067
-93
| -3% | -$24.6K |
2013 Q2
48 quarters
|
|
1198
ONE Gas
OGS
$4.69B
| $836K | ﹤0.01% |
11,627
+4,973
| +75% | +$374K |
2014 Q1
45 quarters
|
|
1199
OGE Energy
OGE
$9.76B
| $835K | ﹤0.01% |
18,826
-232
| -1% | -$10.3K |
2013 Q2
48 quarters
|
|
1200
CVB Financial
CVBF
$3.82B
| $834K | ﹤0.01% |
42,133
+7
| +0% | +$130 |
2023 Q3
7 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.